| Monoclonal antibody | |
|---|---|
| Type | ? |
| Target | CD70 |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| KEGG | |
| Chemical and physical data | |
| Formula | C6476H10006N1726O2028S50 |
| Molar mass | 146.1 kg/mol |
Vorsetuzumab is a monoclonal antibody developed by Seattle Genetics, designed for the treatment of cancer.
Chemical names are: